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Abstract
Several barriers have to be overcome in order to achieve gene expression in target cells, e.g. cellular uptake, endosomal
release and translocation to the nucleus. Nuclear localization sequences (NLS) enhance gene delivery by increasing the
uptake of plasmid DNA (pDNA) to the nucleus. So far, only monopartite NLS were analysed for non-viral gene delivery. In
this study, we examined the characteristics of a novel bipartite NLS like construct, namely NLS Ku70. We synthesized a
dimeric structure of a modified NLS from the Ku70 protein (Ku702-NLS), a nuclear transport active mutant of Ku702-NLS
(s1Ku702-NLS) and a nuclear transport deficient mutant of Ku702-NLS (s2Ku702). We examined the transfection efficiency of
binary Ku702-NLS/DNA and ternary Ku702-NLS/PEI/DNA gene vector complexes in vitro by using standard transfection
protocols as well as the magnetofection method. The application of Ku702-NLS and s1Ku702-NLS increased gene transfer
efficiency in vitro and in vivo. This study shows for the first time that the use of bipartite NLS compounds alone or in
combination with cationic polymers is a promising strategy to enhance the efficiency of non-viral gene transfer.
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Introduction
The transfer of nucleic acids into somatic cells offers new
perspectives for the treatment of lethal acquired or inherited
diseases. To date, effective delivery of the nucleic acids to the
target cells is hindered by extracellular and intracellular biological
barriers. Regarding efficiency, the most potent carrier systems are
based on viral transfection systems like recombinant deficient
retrovirus vectors [1,2].
Non-viral gene delivery is limited by the low endosomal escape
after cellular uptake and the low translocation of DNA into the
nucleus [3,4]. It has been shown that the endosomal escape could
be improved by compacting DNA with the cationic polymer PEI
which compacts and releases DNA efficiently from the endosomes
into the cytosol [5]. To further improve non-viral transfection,
nuclear localization sequences (NLS) have been synthesized and
were used to facilitate nuclear translocation of the DNA. NLS
shuttle proteins into the nucleus by binding to nuclear transport
proteins such as importin a or importin b through the nuclear
pore and are released in the nucleus [6]. The first studies used
NLS covalently bound to pDNA. These studies proved that NLS
can promote the transport of pDNA into the nucleus [7,8], but
covalently bound NLS interfered with the transgene expression of
the pDNA [9]. An easier and less complicated method was
developed by Ritter et al. by binding NLS and DNA in an
electrostatic way [10].
So far, only monopartite NLS were analysed for non-viral gene
delivery. In this study, we examined the characteristics of a novel
bipartite NLS like construct, namely NLS Ku70, for the use as a
non viral gene carrier.
Materials and Methods
Peptide Synthesis
Three peptides were synthesized by the department of medicine
(Institute of Biochemistry, Humboldt-University, Berlin): C-KVTK-
RKHGAAGAASKRPK-G-KVTKRKHGAAGAASKRPK (Ku702-
NLS) as dimeric peptide of the Ku70-NLS, C-ASGSKGARPAKK-
RKPKRGAAHKHAGAKVRKTVTGAKK (s1Ku702-NLS) as a
supposed nuclear transport active mutant of the Ku702-NLS and C-
KTAHSKAARGHTPKGKARVVKAKAGKAKGGKAKPRSR
(s2Ku702) as transport deficient mutant. As far as the intervening
regions of Ku702-NLS are concerned the first and fourth alanine
had to be replaced with glycine because 6 alanines cannot be
synthesized in series. Synthesis of all peptides started with
glycine. The free sulfhydryl groups of the cysteines were modified
by dithiopyridin reaction in order to protect them of oxidation
[11].
Cloning of b-galactosidase fusion proteins
For subcloning of plasmid DNA coding b-galactosidase fusion
proteins, we used pVAX1/lacZ plasmids (Invitrogen. UK). The
coding and non-coding strand of Ku702-NLS-, s1Ku702-NLS and
s2Ku702 were synthesized by Biomers (Ulm, Germany). All
annealed oligonucleotides were cloned into the pVAX1/lacZ
plasmid between NheI and BamHI restriction sites. The
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b-galactosidase DNA sequence there existed one start codon and
one excess nucleotide. Thereby it could not be ensured that the
Ku702-NLS-b-Galactosidase fusion protein could be read com-
pletely and correctly by DNA polymerase. The excess nucleotide
led to a frame shift; therefore the open reading frame of b-
galactosidase DNA sequence was disarranged. In order to exclude
the nucleotide sequence GATG we conducted a site directed
mutagenesis. Hence, we designed a forward primer (59-TT-
GAATTCTGCAGATCGAAACATAGATCCCGTCGTTTTA-
CAA-39) and a reverse primer (59-TTGTAAAACGACGG-
GATCTATGTTTCGATCTGCAGAATTCCA-39) flanking the
nucleotide sequence GATG. Using proof reading enzyme PFU II
Ultra (Stratagene, CA, USA) we conducted an inverse PCR of the
already cloned plasmid DNA by using the following PCR protocol:
2 min at 94uC denaturation, 18 cycles of 20 sec denaturation at
95uC, 20 sec annealing of primer at 45uC, 90 sec elongation at
68uC, and accordingly 3 min proof reading at 68uC. Afterwards,
the new plasmids were digested with enzyme DpnI (Fermentas, St.
Leon-Rot, Germany). Again, after transformation in E. coli, new
plasmids were identified by gel electrophoresis using 1% agarose
gel and by sequencing (GATC Biotech AG, Konstanz, Germany).
Then, the plasmids pVAX1/lacZ-Ku702-NLS, pVAX1/lacZ-
s1Ku702-NLS and pVAX1/lacZ-s2Ku702 were transformated
into E. coli strain DH10B (ElectroMAX DH10B Cells, Invitrogen,
Karlsruhe, Germany), isolated and purified by using NucleoBondH
EF plasmid purification kits (Macherey-Nagel, Du ¨ren, Germany).
Plasmid DNA
The pCLuc containing firefly luciferase (a gift by Ernst Wagner,
department of pharmacy, University of Munich,) and pEGFP-N1
containing enhanced green fluorescent Protein (Clontech, Palo
Alto, CA, USA) were used for in vitro transfections. In vivo
experiments were conducted with ccc-pCp-Luc coding for
luciferase (Invitrogen, UK). For b-galactosidase experiments we
used pVR1411 containing SV40-NLS (Biomers, Ulm, Germany),
pVAX1/lacZ (Invitrogen, UK) containing b-galactosidase report-
ing gene as well as pVAX1/lacZ-Ku702-NLS, pVAX1/lacZ-
s1Ku702-NLS and pVAX1/lacZ-s2Ku702.
Size measurement
Particle size was determined by dynamic light scattering
(Brookhaven Instruments Corporation, Austria). Gene vector
complexes were generated as described above in double-distilled
water and PBS. Measurements were performed using the following
settings: 10 sub-run measurements per sample; viscosity for water
0.89 cPa; beam mode F(Ka) J 1.50 (Smoluchowsky); and
temperature 25uC.
Cell Culture
BEAS-2B cells (ATCC No. CRL-9609) and 16HBE14o
2 cells
(Prof. Dr. Dieter C. Gruenert, University of Vermont, Burlington,
VT, USA), a human bronchial epithelial cell line, and HELA
(DSMZ No: ACC 57, Germany), a cervical carcinoma cell line,
were cultured in minimal essential medium (MEM, Gibco/
Invitrogen, Karlsruhe, Germany) containing 10% fetal bovine
serum (PAA Laboratories, Austria). All cells were maintained at
37uC in a 5% CO2 humidified air atmosphere.
Preparation of Gene Vector Complexes
Gene vector complexes were generated in HBS (150 mM NaCl,
10 mM HEPES, pH 7.4) or PBS. For formulating binary gene vector
complexes 0.5 mg DNA and a varying amount of GTA depending on
the 6 ratio were dissolved in 75 ml of solvent. The DNA solution was
pipetted to the GTA solution and mixed vigorously by pipetting up
and down. The complexes were incubated at room temperature for
20 min before use. Ternary complexes were formulated in the same
way, but 0.5 mg of DNA, NLS and PEI (average molecular mass of
25 kDA; Sigma Aldrich, Deisenhofen, Germany; dialyzed against
water, 12–14-kDa molecular mass cut-off and adjusted to pH 7) were
diluted in 25 ml solvent per GTA. Initially, DNA solution was pipetted
to the NLS solution and incubated for 10 min. Accordingly PEI was
added, the ternary solution was mixed vigorously and incubated for
further 10 min before use.
In vitro electroporation of Ku702-NLS-b-galactosidase
fusion proteins
Electroporation was only used for b-galactosidase experiments
and performed with BioRad GenPulser II apparatus.
In vitro transfection/magnetofection and luciferase
activity measurement
For transfection and magnetofection experiments, cells (10.000/
well) were seeded in 96 well plates (Techno Plastic Products AG,
Trasadingen, Suisse). For transfection experiments, complexes
were pipetted in each well and incubated. 4 h later, the medium
was replaced with 200 ml 10% FCS containing MEM supple-
mented with 0.1% (v/v) penicillin/streptomycin and 0.5% (v/v)
gentamycin (Gibco/Invitrogen). 24 h later luciferase activity was
measured after cell lysis by addition of 100 ml lysis buffer to each
well (250 mM Tris, 0.1% Triton, ph=7.8) and incubated at room
temperature for 15 min. [12]. Luciferase expression was measured
with Wallac Victor
2/1420 Multilabel Counter (PerkinElmer;
Rodgau-Ju ¨gesheim, Germany). The protein content was deter-
mined by a standard Bio-Rad protein assay (Bradford method).
Magnetofection experiments were performed accordingly, but
after having pipetted complexes to the wells, 96 well plates were
placed on a sintered Nd-Fe-B magnet (NeoDelta; remanence Br,
1080–1150 mT), purchased from IBS Magnet (Berlin, Germany).
Dimension of the magnet: cylindrical; d=6 mm, h=5 mm,
inserted in an acrylic glass template in 96-well microplate format
with strictly alternating polarization. Cells were incubated for
20 minutes instead of 4 h for transfection.
FACS analysis
For FACS measurements, 100,000 cells per well were seeded in
24-well plates (TPP, Trasadingen, Switzerland). Magnetofection
was performed as described above. For FACS measurements cells
were washed with PBS. Then the cells were trypsinized and
measured using a Becton Dickinson FACScan (San Jose, USA).
Animal experiments and administration of gene vectors
into the lung
Female BALB/c mice were purchased form Janvier (Elevage
Janvier, Le Genst St. Isle, France) and maintained under specific
pathogen free conditions. All experiments were approved and
controlled by local ethic committee and conducted according to
the guidelines of the German law of protection of animal life.
Animals were anaesthetized by intraperitoneal injection of a
mixture of medetomidine, midazolam, and fentanyl. The amount
of plasmid DNA administered per mouse was 30 mg of CpG-free
pCpGLuc. Gene transfer agents were diluted in double distilled
water (Fresenius AG, Bad Homburg, Germany) in a volume of
100 ml per mouse. Firstly, branched PEI (N/P-ratio=10) and
Ku702-NLS-, s1Ku702-NLS and s2Ku702 (+/2 ratio=5) were
mixed and incubated for 10min. Afterwards, DNA solution was
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gene transfer solution was drop-wise pipetted onto the nose of each
mouse. After application, mice were administered an antidote dose
which consisted of atipamezol (50 mg/kg), flumazenil (10 mg/kg)
and naloxon (24 mg/kg). The mice recovered from anaesthesia
within 15 min and no adverse effects of the anaesthesia were
observed. 24 h later, the efficiency of the gene vector application
was measured by bioluminescence (IVIS 100 imaging system;
Xenogen, Almeda, CA). For this purpose, mice were anaesthetized
again. Signals were quantified and analyzed using the Living
Image Software ver. 2.50. After imaging, anaesthetized mice were
killed. Then, the posterior vena cava exit was cut and 1 ml of an
isotonic sodium chloride solution was perfused slowly into the right
heart in order to wash blood from the lungs and to avoid
interference with the subsequent luciferase assay. The lungs were
dissected from animals, frozen in liquid nitrogen and stored at
280 C. For the measurement of luciferase activity, minced lungs
were each mixed with 400 ml of cell lysis buffer with addition of
protease inhibitors (Roche Protease Inhibitor Cocktail Tablets).
Samples were vortexed and centrifuged at 10,000 g at 4 C for
10 min. 100 ml of supernatant were measured for luciferase
activity in a Lumat LB 9507 instrument (Berthold, Bad Wildbad,
Germany) in duplicates by injecting 100 ml luciferin assay buffer.
The emitted light was measured over 30 sec. The background was
subtracted from the reported values.
Statistical Analysis
Statistical analyses were carried out using IBM SPSS 19.0
(Chicago, IL, U.S.A.). Means and one standard deviation of a
representative experiment performed in triplicates are reported. A
p value,0.05 was considered to be significant. Intergroup analyses
were carried out using the Mann-Whitney U test as the data were
not normally distributed in all groups.
Results
Proof of nuclear localization activity
First, we analyzed the nuclear localization activity of the newly
synthesized bipartite peptides Ku702-NLS, s1Ku702-NLS, and
s2Ku702. These examinations had to be conducted because
Ku702-NLS was synthesized as a dimer and the intervening region
of Ku702-NLS had been changed which could have influenced the
nuclear localization activity. The analysed cells showed the typical
blue b-galactosidase coloration after staining with b-galactosidase
staining solution [13]. If the tested peptides had characteristics of a
nuclear localization sequence only the nucleus should stain blue.
Otherwise the complete cytosol would show the blue staining.
Using this method, we could show that Ku702-NLS and s1Ku702-
NLS had nuclear localization activity, whereas s2Ku702 did not
show any nuclear localization activity (Figure 1).
Biophysical properties of binary and ternary Ku702–NLS
gene vector complexes
The size of particles is influenced by the solvent in such a way
that ionic solvents enlarge particle size, and non-ionic solvents like
distilled water result in a smaller size of the complexes
[11,14,15,16,17]. Analysing the synthesized gene vector complexes
for a period of 10 minutes, we could show that Ku702-NLS/DNA,
s1Ku702-NLS/DNA and s2Ku702/DNA complexes (65) that
were generated in distilled water had a constant size of about
80 nm and transMag
PEI/DNA complexes of about 190 nm.
Ternary Ku702-NLS/transMag
PEI/DNA, s1Ku702-NLS/trans-
Mag
PEI/DNA and s2Ku702/transMag
PEI/DNA are just as large
as transMag
PEI/DNA complexes and constant in size for about
10 minutes. Ternary gene vector complexes which were generated
in PBS increased continuously during 20 minutes of measurement.
All complexes showed a comparable size of about 300 to 400 nm.
Comparison of the bipartite Ku702–NLS with monomeric
nuclear localization sequences
Ku702-NLS, s1Ku702-NLS were analyzed in comparison to
monopartite nuclear localization sequences. We used NLSV404
(origin of SV40 virus) and TAT2, and their analogous nuclear
transport deficient mutants cNLS and TAT2M1, as well as
s2Ku702. Gene vector complexes were generated with charge ratio
of 6=5 and transfected to BEAS-2B cells. Gene transfer
efficiency mediated by Ku702-NLS was significantly higher as
compared to TAT2 or to NLS404. The same was the case for
s1Ku702-NLS (Figure 2). This study clearly shows an advantage of
the bipartite NLS over monopartite NLS.
Transfection efficiency depending on the +/2ratio
Plasmid DNA was complexed with Ku702-NLS or with
s2Ku702. Transfections were performed with different charge
Figure 1. Intracellular localization of b-galactosidase fusion proteins. BEAS-2B cells were electroporated with 10 mg b-galactosidase coding
plasmid DNA. All images show the typical blue b-galactosidase staining. Images (a) and (b) point that Ku702-NLS and s1Ku702-NLS show nuclear
localization signal activity. The exclusive blue staining of nuclei is clearly visible. The s2Ku702 shows staining of the cytosol. The NLS large antigen (e)
was used as positive control for nuclear localisation and b-galactosidase without NLS (d) as negative control.
doi:10.1371/journal.pone.0024615.g001
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BEAS-2B cells and 16-HBE cells, we found that gene transfer
efficiency at a ratio of 6=5 was highest and future used.
Ternary gene vector complexes: combination of Ku702–
NLS with polyethylenimine (PEI)
In a first step, we formulated ternary gene vector complexes
with a DNA dose of 0.25 mga ta6 ratios of 5, 2.5, 1.25, 0.625 and
0.313. As a control, binary PEI/DNA (6=10) complexes were
used. Ku702-NLS/PEI/DNA and s2Ku702/PEI/DNA mediated
higher gene transfer efficiency than binary PEI/DNA complexes.
Transgene expression mediated by Ku702-NLS/PEI/DNA is
about 1.7-fold to 8-fold higher as compared to transgene
expression mediated by PEI/DNA. Using 6 ratio of 5 Ku702-
NLS/PEI/DNA complexes showed the most efficient gene
delivery compared to PEI/DNA. 6 ratios of 2,5 and 5 tested
for Ku702-NLS/PEI are about 1.7-fold to 3.4-fold higher
compared to s2Ku702/PEI (data not shown). Furthermore, we
analyzed the transfection efficiency using the magnetofection
method [18]. [19]. Gene vector complexes were formulated in
PBS. DNA doses 0.03125, 0.0625, 0.125, 0.25 and 0.5 mg were
analyzed. Ku702-NLS/transMag
Pei/DNA complexes solvented in
PBS mediated 1.7-fold to 6-fold higher transgene expression
compared to transMag
Pei/DNA. Transfection efficiency of Ku702-
NLS/transMag
Pei/DNA compared to s2Ku702/PEI/DNA is
about 1.1-fold to 3-fold higher (Figure 3).
Quantification of the number of transfected cells
The number of transfected cells was investigated with FACS
analysis. 16HBE14o
2 and BEAS-2B cells were transfected using
magnetofection. The highest number of EGFP positive
16HBE14o
2 cells was found in the following order: Ku702-NLS/
transMag
PEI.s2Ku702/transMag
PEI.transMag
PEI (10.4%.8.2%
.2.2%). The incremental factor of luciferase expression (Ku702-
NLS/transMag
PEI: 8-fold, s2Ku702/transMag
PEI: 2.4-fold) com-
pared to incremental factor of a number of transfected cells
(Ku702-NLS/transMag
PEI: 1.5-fold, s2Ku702/transMag
PEI:1 . 5 -
fold) clarifies that the Ku702-NLS/transMag
PEI mediated lucif-
erase expression is 5.3-fold (s2Ku702/transMag
PEI: 1.6-fold)
compared to the number of transfected cells. In this respect
Ku702-NLS/transMag
PEI enhances gene transfer by enhancing
transgene expression of each cell, but not by the number of
transfected cells.
In vivo application of ternary Ku702-NLS/PEI/DNA and
s1Ku702-NLS/PEI/DNA complexes using nasal instillation
Using the IVIS in vivo imaging method it could be established
that every type of gene vector complex was able to mediate gene
Figure 2. Ku702-NLS in comparison to monopartite nuclear localization sequences. BEAS-2B cells were transfected with Ku702-NLS/DNA
complexes or the monopartite active NLS (TAT)2 or NLSV404, and their nuclear transport deficient sequences (control) NLS (TAT2M1 or cNLS). All the
complexes were generated in HBS (charge 6=5). Transgene expression of Ku702-NLS and s1Ku702-NLS was significantly higher (p,0.05, Mann-
Whitney-U-Test) compared to the respective monopartite NLS (TAT)2 or NLSV404. Transgene expression of Ku702-NLS and s1Ku702-NLS compared to
the control peptide s2Ku702 was close to significance. This study clearly suggests an advantage of the bipartite NLS over monopartite NLS.
doi:10.1371/journal.pone.0024615.g002
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of the lungs of the tested groups of mice. In some contrast to the in
vitro data, the Ku702-NLS/PEI/DNA mediated gene transfer was
about 20% lower than PEI/DNA, but this effect was not
statistically significant. s1Ku702-NLS/PEI/DNA mediated gene
transfer was about 12% and s2Ku702/PEI/DNA mediated gene
transfer about 28% higher compared to PEI/DNA (n.s.). In
addition to the in vivo measurements with IVIS, lung homo-
genisates were analyzed for the presence of luciferase activity. In
this analysis, the Ku702-NLS/PEI mediated gene transfer was
about 46% higher, s1Ku702-NLS/PEI/DNA about 77% and
s2Ku702/DNA about 9% higher compared to PEI/DNA. The
values are significantly different from control (p#0.043; n=4)
(Figure 4). Although the IVIS measurements may not have
reflected the in vitro results, the analyses in lung homogenisates
partly confirmed the in vitro data.
Discussion
It is known that the nuclear membrane in eukaryotic cells is a
major barrier for efficient gene transfer using non-viral vectors.
Based on this information we pursued a new strategy of using a
bipartite nuclear localization sequence of the Ku70 protein in
order to develop a more efficient non-viral gene transfer system
compared to classical non viral gene transfer agents. This Ku70
protein is a subunit of the Ku protein which was found in patients
with systemic lupus erythematosus and scleroderma-polymyositis
overlap syndrome. This protein is involved in DNA double-strand
break repair and transcription. The Ku70 subunit consists of two
basic subregions and a nonbasic intervening region [20,21].
Insofar, this NLS was interesting for our examination because the
intervening region consisting of the aminoacids DNEGSG can be
substituted by six alanines without any loss of NLS-functionality
[21]. Substituting the negatively charged aminoacids could
improve the binding intensity between NLS and pDNA. Rudolph
et al. observed that the application of dimeric NLS reached the
most efficient gene delivery in their study [11]. In analogy to this
study, we characterized this dimeric structure of the Ku70 NLS for
the use as a non viral gene carrier.
Firstly, NLS activity of the newly synthesized Ku702-NLS and
s1Ku702-NLS was confirmed by using b-galactosidase fusionpro-
teins. Comparing the transfection efficacy of the newly synthesized
bipartite NLS with standard polyfection (PEI/DNA) we found
better transfection results of Ku702-NLS when using lower DNA
doses (0.125 mg–0.25 mg). In contrast, PEI/DNA mediated 2.5-
fold to 7-fold higher transfection efficiency in the higher dose
range of DNA (0.125 mg–0.5 mg). As a result of better transfection
efficiencies using lower DNA doses, the amount of DNA, peptides
and PEI could be reduced considerably. Lower DNA doses lead to
a reduction of toxic effects by gene transfer complexes. Therefore
we used a DNA dose of 0.25 mg in the following transfections.
Using FACS analysis it was clearly visible that by transfecting
Ku702-NLS/transMag
Pei/DNA complexes the number of trans-
fected cells was higher compared to binary transMag
Pei/DNA
complexes. This result could be confirmed on both cell lines.
Ku702-NLS enhanced gene expression stronger by enhancing
Figure 3. Transfection efficiency of ternary gene vector complexes using transMag
PEI and different solvents. BEAS-2B cells were
transfected with gene vector complexes. Transgene expression of Ku702-NLS/transMag
Pei/DNA is more efficient than s2Ku702/transMag
Pei and
transMag
Pei/DNA. *p=0.02 and **p=0.001.
doi:10.1371/journal.pone.0024615.g003
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transfected cells. This result was not observed after transfections
with s2Ku702. The better transfection results of Ku702-NLS
compared to s2Ku702 rely on the fact that Ku702-NLS is a NLS.
The results of in vitro transfections revealed that Ku702-NLS/
PEI/DNA particles are able to transfect effectively human
bronchoepithelial cells. For this reason an in vivo application of
Ku702-NLS/PEI/DNA and s1Ku702-NLS/PEI/DNA complexes
was conducted. In these experiments an enhancement of gene
transfer mediated from Ku702-NLS (46%) or s1Ku702-NLS (77%)
compared to PEI/DNA complexes was observed.
In conclusion, ternary gene vector complexes consisting of
Ku702-NLS, PEI and DNA represent an effective gene delivery
system. A clear enhancement of transgene expression was
observed compared to PEI/DNA. Differences between Ku702-
NLS and s1Ku702-NLS are marginal, compared to the nuclear
transport-deficient s2Ku702. Gene transfer efficiency using the
bipartite NLS Ku702-NLS improves transgene expression com-
pared to monopartite NLS. For in vivo applications Ku702-NLS
and s1Ku702-NLS have to be further optimized. Ku702-NLS and
s1Ku702-NLS promise gene transfer agents in the field of non-
viral gene delivery.
Author Contributions
Conceived and designed the experiments: JR CR. Performed the
experiments: JM CM AB. Analyzed the data: JR RM. Contributed
reagents/materials/analysis tools: CM AB. Wrote the paper: JM JR CR.
References
1. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N,
et al. (2003) LMO2-associated clonal T cell proliferation in two patients after
gene therapy for SCID-X1. Science. pp 415–419.
2. Honigman A, Zeira E, Ohana P, Abramovitz R, Tavor E, et al. (2001) Imaging
transgene expression in live animals. Mol Ther 4: 239–249.
3. Plank C, Oberhauser B, Mechtler K, Koch C, Wagner E (1994) The influence of
endosome-disruptive peptides on gene transfer using synthetic virus-like gene
transfer systems. J Biol Chem 269: 12918–12924.
4. Pollard H, Remy JS, Loussouarn G, Demolombe S, Behr JP, et al. (1998)
Polyethylenimine but not cationic lipids promotes transgene delivery to the
nucleus in mammalian cells. J Biol Chem 273: 7507–7511.
5. Boussif O, Lezoualc’h F, Zanta MA, Mergny MD, Scherman D, et al. (1995) A
versatile vector for gene and oligonucleotide transfer into cells in culture and in
vivo: polyethylenimine. Proc Natl Acad Sci U S A 92: 7297–7301.
6. Gorlich D, Kutay U (1999) Transport between the cell nucleus and the
cytoplasm. Annu Rev Cell Dev Biol 15: 607–660.
7. Ciolina C, Byk G, Blanche F, Thuillier V, Scherman D, et al. (1999) Coupling of
nuclear localization signals to plasmid DNA and specific interaction of the
conjugates with importin alpha. Bioconjug Chem 10: 49–55.
8. Zanta MA, Belguise-Valladier P, Behr JP (1999) Gene delivery: a single nuclear
localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc
Natl Acad Sci U S A 96: 91–96.
9. Sebestyen MG, Ludtke JJ, Bassik MC, Zhang G, Budker V, et al. (1998) DNA
vector chemistry: the covalent attachment of signal peptides to plasmid DNA.
Nat Biotechnol 16: 80–85.
10. Ritter W, Plank C, Lausier J, Rudolph C, Zink D, et al. (2003) A novel
transfecting peptide comprising a tetrameric nuclear localization sequence. J Mol
Med 81: 708–717.
11. Rudolph C, Plank C, Lausier J, Schillinger U, Muller RH, et al. (2003)
Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of
transferring plasmid DNA into cells. J Biol Chem 278: 11411–11418.
12. Surovoy A, Flechsler I, Gaunitz F, Papke M, Jung G (1998) Simple and fast
microscale procedure for transfection and quantification of reporter gene
expression in eukaryotic cells. Adv Exp Med Biol 451: 457–460.
13. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, et al. (1994) Tat-mediated
delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A 91:
664–668.
14. Erbacher P, Bettinger T, Belguise-Valladier P, Zou S, Coll JL, et al. (1999)
Transfection and physical properties of various saccharide, poly(ethylene
glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med 1: 210–
222.
15. Ogris M, Steinlein P, Carotta S, Brunner S, Wagner E (2001) DNA/
polyethylenimine transfection particles: influence of ligands, polymer size, and
PEGylation on internalization and gene expression. AAPS Pharm Sci 3: E21.
16. Ogris M, Steinlein P, Kursa M, Mechtler K, Kircheis R, et al. (1998) The size of
DNA/transferrin-PEI complexes is an important factor for gene expression in
cultured cells. Gene Ther 5: 1425–1433.
17. Wightman L, Kircheis R, Rossler V, Carotta S, Ruzicka R, et al. (2001)
Different behavior of branched and linear polyethylenimine for gene delivery in
vitro and in vivo. J Gene Med 3: 362–372.
Figure 4. Analysing luciferase expression in lung homogenisates after nasal instillation of gene transfer agents. 1, Ku702-NLS/PEI/
DNA; 2, s1Ku702-NLS/PEI/DNA; 3, s2Ku702/PEI/DNA; 4, PEI/DNA. Gene vector complexes were formulated as follows: 30 mg DNA; NLS: 6 ratio=5; PEI:
N/P ratio=10. Luciferase activity was measured in lung homogenisates 24 h after application of gene vectors. Values between Ku702-NLS/PEI and PEI
significantly different (p#0.043; n=4). Statistical analysis was performed using the Mann-Whithney-U test.
doi:10.1371/journal.pone.0024615.g004
Ku702-NLS as Bipartite Nuclear Localization
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e2461518. Plank C, Schillinger U, Scherer F, Bergemann C, Remy JS, et al. (2003) The
magnetofection method: using magnetic force to enhance gene delivery. Biol
Chem 384: 737–747.
19. Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, et al. (2002)
Magnetofection: enhancing and targeting gene delivery by magnetic force in
vitro and in vivo. Gene Ther 9: 102–109.
20. Koike M (2002) Dimerization, translocation and localization of Ku70 and Ku80
proteins. J Radiat Res (Tokyo) 43: 223–236.
21. Koike M, Ikuta T, Miyasaka T, Shiomi T (1999) The nuclear localization signal
of the human Ku70 is a variant bipartite type recognized by the two components
of nuclear pore-targeting complex. Exp Cell Res 250: 401–413.
Ku702-NLS as Bipartite Nuclear Localization
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e24615